common glp 1 agonist Frontiers How GLP-1 Receptor Agonists Evolved
Description
Use should always occur under clinical supervision with individualized evaluation, monitoring, and follow-up
OG was funded by Brain research UK
Zelniker, T
doi: 10.4239/wjd.v1.i1.8
Weight regain is very common after stopping a GLP-1on average, up to two-thirds of the lost weight is regained within one year
The availability of this pill could make weight-loss treatment more accessible to a large number of Americans who have avoided injectable options due to expense, discomfort with needles or rigid dosing rules
